Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ann Surg Oncol. 2024 Nov;31(12):7950-7956. doi: 10.1245/s10434-024-15528-x. Epub 2024 Aug 16.
Atypical intradermal smooth muscle neoplasm, also commonly termed cutaneous leiomyosarcoma, is a soft tissue tumor with a low risk of aggressive behavior. These lesions arise in the dermis with possible superficial subcutaneous extension, demonstrate cytologic atypia, and often show mitotic activity.
A retrospective review of patient demographics, tumor characteristics, and treatment methods was conducted in a consecutive series of patients presenting to MD Anderson Cancer Center (MDACC) from 2002 to 2021 (n = 95). All pathology was reviewed by MDACC pathologists and determined to be atypical intradermal smooth muscle neoplasm.
Median age at diagnosis was 58 years (range 22-86), and 74% were male. Ninety-five percent (n = 90) of patients identified as White, non-Hispanic. Most tumors were slow-growing, solitary, and painless nodules. Tumors were in the lower extremities (44.2%), followed by the upper extremity (28.4%), trunk (22.1%), and head and neck (5.2%). All patients (n = 44, 46.3%) who had a punch/incisional biopsy for diagnostic purposes had a subsequent tumor excision. Unplanned excision or excisional biopsy was performed on the remaining 46 (48%) patients. Of this subset, 41 of the 46 aforementioned patients (89%) had positive margins and underwent re-excision. Final pathology in 25/38 (66%) re-excision specimens was negative for residual tumor despite an initial positive margin. Two patients in the cohort had local recurrence 2 and 3 years after initial surgery. Both patients had positive margins, underwent excision of the recurrent tumor, and remain free of disease. After median follow-up of 6.9 years (range 1 day-18 years), 5-year recurrence-free survival was 96% and overall survival (OS) of the entire cohort was 78%.
In this study of consecutive patients presenting with atypical intradermal smooth muscle neoplasm, we found good OS and local control after definitive surgical excision with negative margins, including excisional biopsy with close margins. Atypical intradermal smooth muscle neoplasm is unlikely to metastasize and has an excellent prognosis. Guidelines to determine optimal surveillance strategies for these patients should be revisited.
非典型真皮平滑肌肿瘤,也常被称为皮肤平滑肌肉瘤,是一种具有低侵袭性行为风险的软组织肿瘤。这些病变发生在真皮内,可能伴有浅表皮下延伸,表现出细胞学异型性,并且通常具有有丝分裂活性。
回顾性分析了 2002 年至 2021 年期间连续就诊于 MD 安德森癌症中心(MDACC)的患者的人口统计学特征、肿瘤特征和治疗方法(n=95)。所有的病理学检查均由 MDACC 的病理学家进行,并确定为非典型真皮平滑肌肿瘤。
中位诊断年龄为 58 岁(范围 22-86 岁),74%为男性。95%(n=90)的患者为白人,非西班牙裔。大多数肿瘤为生长缓慢、单发、无痛性结节。肿瘤位于下肢(44.2%),其次是上肢(28.4%)、躯干(22.1%)和头颈部(5.2%)。所有因诊断目的而行切取/切开活检的患者(n=44,46.3%)随后均行肿瘤切除术。剩余的 46 例(48%)患者行计划外切除术或切除术。在这一组中,46 例中有 41 例(89%)切缘阳性,并再次行切除术。25/38 例(66%)再次切除标本的最终病理检查均为阴性,尽管最初的切缘阳性。在队列中有 2 例患者在初次手术后 2 年和 3 年出现局部复发。这 2 例患者的切缘均为阳性,行复发性肿瘤切除术,目前无疾病。中位随访 6.9 年(范围 1 天-18 年)后,5 年无复发生存率为 96%,全组患者的总生存率(OS)为 78%。
在这项对连续就诊的非典型真皮平滑肌肿瘤患者的研究中,我们发现,在切缘阴性的情况下,行确定性手术切除(包括切缘较近的切除术)后,患者具有良好的 OS 和局部控制率。非典型真皮平滑肌肿瘤不太可能转移,预后良好。应重新审视确定这些患者最佳监测策略的指南。